Amirhossein Jalali

Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".

Journal: Prostate cancer and prostatic diseases

Published: May 25, 2026

Evaluating the Neutrophil-Lymphocyte Ratio as a Predictor of Long-Term Oncological and Survival Outcomes in Patients Treated Surgically for Breast Cancer.

Journal: Clinical breast cancer

Published: May 06, 2025

Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancer.

Journal: Cancer pathogenesis and therapy

Published: May 06, 2025

Clinical impact of MRI-based risk calculators for prostate cancer diagnosis: a systematic review and meta-analysis.

Journal: Prostate cancer and prostatic diseases

Published: April 23, 2025

Comparing logistic regression and machine learning for obesity risk prediction: A systematic review and meta-analysis.

Journal: International journal of medical informatics

Published: November 04, 2024

Lymphoma follow-up pathway: A 10-year study to guide practice.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: October 24, 2024

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

Journal: Canadian journal of surgery. Journal canadien de chirurgie

Published: January 04, 2024

Designing infographics in health research with patients and the public: A scoping review protocol.

Journal: PloS one

Published: June 20, 2023

An Exploratory Study of Capacity Assessment in Medical Practice in Ireland.

Journal: European journal of health law

Published: May 01, 2023

P53 loss of heterozygosity (LOH) in formalin-fixed paraffin-embedded leiomyosarcoma (LMS): a novel report.

Journal: Irish journal of medical science

Published: October 25, 2022

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort.

Journal: Current oncology (Toronto, Ont.)

Published: September 06, 2022

Journal: Journal of personalized medicine

Published: May 23, 2022

Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".

Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".

Evaluating the Neutrophil-Lymphocyte Ratio as a Predictor of Long-Term Oncological and Survival Outcomes in Patients Treated Surgically for Breast Cancer.

Evaluating the Neutrophil-Lymphocyte Ratio as a Predictor of Long-Term Oncological and Survival Outcomes in Patients Treated Surgically for Breast Cancer.

Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancer.

Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancer.

Clinical impact of MRI-based risk calculators for prostate cancer diagnosis: a systematic review and meta-analysis.

Clinical impact of MRI-based risk calculators for prostate cancer diagnosis: a systematic review and meta-analysis.

Comparing logistic regression and machine learning for obesity risk prediction: A systematic review and meta-analysis.

Comparing logistic regression and machine learning for obesity risk prediction: A systematic review and meta-analysis.

Lymphoma follow-up pathway: A 10-year study to guide practice.

Lymphoma follow-up pathway: A 10-year study to guide practice.

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

Designing infographics in health research with patients and the public: A scoping review protocol.

Designing infographics in health research with patients and the public: A scoping review protocol.

An Exploratory Study of Capacity Assessment in Medical Practice in Ireland.

An Exploratory Study of Capacity Assessment in Medical Practice in Ireland.

P53 loss of heterozygosity (LOH) in formalin-fixed paraffin-embedded leiomyosarcoma (LMS): a novel report.

P53 loss of heterozygosity (LOH) in formalin-fixed paraffin-embedded leiomyosarcoma (LMS): a novel report.

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort.

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort.

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©.

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©.